Literature DB >> 21147908

TMEM70 mutations are a common cause of nuclear encoded ATP synthase assembly defect: further delineation of a new syndrome.

Ronen Spiegel1, Morad Khayat, Stavit A Shalev, Yoseph Horovitz, Hanna Mandel, Eli Hershkovitz, Flora Barghuti, Avraham Shaag, Ann Saada, Stanley H Korman, Orly Elpeleg, Ido Yatsiv.   

Abstract

BACKGROUND: The TMEM70 gene defect was recently identified as a novel cause of autosomal recessive ATP synthase deficiency. Most of the 28 patients with TMEM70 disorder reported to date display a distinctive phenotype characterised by neonatal onset of severe muscular hypotonia hypertrophic cardiomyopathy, facial dysmorphism, profound lactic acidosis, and 3-methylglutaconic aciduria. Almost all share a common Roma descent and are homozygous for a single founder splice site mutation.
METHODS: Six new patients from four separate families, with clinical and biochemical diagnosis of ATP synthase deficiency, were studied. TMEM70 sequence analysis of the three exons and their flanking splice junction consensus sequences was performed in all patients. In addition their clinical phenotype and disease course was strictly studied.
RESULTS: Four novel deleterious homozygous TMEM70 mutations were identified. The previously described clinical spectrum was expanded to include infantile onset cataract, early onset gastrointestinal dysfunction and congenital hypertonia with multiple contractures resembling arthrogryposis. The first characterisation of fetal presentation of the syndrome is also provided, featuring significant intrauterine growth retardation, severe oligohydramnios, fetal hypotonia, and myocardial wall thickening.
CONCLUSIONS: The current report corroborates the previously described unique phenotype of TMEM70 deficiency. The study identifies TMEM70 gene defect as a pan-ethnic disorder and further redefines it as the most common cause of nuclear-origin ATP synthase deficiency.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147908     DOI: 10.1136/jmg.2010.084608

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  21 in total

Review 1.  Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors.

Authors:  Alessandra Torraco; Susana Peralta; Luisa Iommarini; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-02-04       Impact factor: 4.160

2.  The INA complex facilitates assembly of the peripheral stalk of the mitochondrial F1Fo-ATP synthase.

Authors:  Oleksandr Lytovchenko; Nataliia Naumenko; Silke Oeljeklaus; Bernhard Schmidt; Karina von der Malsburg; Markus Deckers; Bettina Warscheid; Martin van der Laan; Peter Rehling
Journal:  EMBO J       Date:  2014-06-18       Impact factor: 11.598

Review 3.  Metabolic biology of 3-methylglutaconic acid-uria: a new perspective.

Authors:  Betty Su; Robert O Ryan
Journal:  J Inherit Metab Dis       Date:  2014-01-10       Impact factor: 4.982

4.  A mutation in the TMEM65 gene results in mitochondrial myopathy with severe neurological manifestations.

Authors:  Aisha Nazli; Adeel Safdar; Ayesha Saleem; Mahmood Akhtar; Lauren I Brady; Jeremy Schwartzentruber; Mark A Tarnopolsky
Journal:  Eur J Hum Genet       Date:  2017-03-15       Impact factor: 4.246

5.  Neonatal onset of mitochondrial disorders in 129 patients: clinical and laboratory characteristics and a new approach to diagnosis.

Authors:  Tomas Honzik; Marketa Tesarova; Martin Magner; Johannes Mayr; Pavel Jesina; Katerina Vesela; Laszlo Wenchich; Karol Szentivanyi; Hana Hansikova; Wolfgang Sperl; Jiri Zeman
Journal:  J Inherit Metab Dis       Date:  2012-01-10       Impact factor: 4.982

6.  CLPB variants associated with autosomal-recessive mitochondrial disorder with cataract, neutropenia, epilepsy, and methylglutaconic aciduria.

Authors:  Carol Saunders; Laurie Smith; Flemming Wibrand; Kirstine Ravn; Peter Bross; Isabelle Thiffault; Mette Christensen; Andrea Atherton; Emily Farrow; Neil Miller; Stephen F Kingsmore; Elsebet Ostergaard
Journal:  Am J Hum Genet       Date:  2015-01-15       Impact factor: 11.025

7.  TMEM70 deficiency: long-term outcome of 48 patients.

Authors:  Martin Magner; Veronika Dvorakova; Marketa Tesarova; Stella Mazurova; Hana Hansikova; Martin Zahorec; Katarina Brennerova; Vladimir Bzduch; Ronen Spiegel; Yoseph Horovitz; Hanna Mandel; Fatma Tuba Eminoğlu; Johannes Adalbert Mayr; Johannes Koch; Diego Martinelli; Enrico Bertini; Vassiliki Konstantopoulou; Joél Smet; Shamima Rahman; Alexander Broomfield; Vesna Stojanović; Carlo Dionisi-Vici; Rudy van Coster; Eva Morava; Eva Morava-Kozicz; Wolfgang Sperl; Jiri Zeman; Tomas Honzik
Journal:  J Inherit Metab Dis       Date:  2014-10-18       Impact factor: 4.982

8.  TMEM70: a mutational hot spot in nuclear ATP synthase deficiency with a pivotal role in complex V biogenesis.

Authors:  Alessandra Torraco; Daniela Verrigni; Teresa Rizza; Maria Chiara Meschini; Martha Elisa Vazquez-Memije; Diego Martinelli; Marzia Bianchi; Fiorella Piemonte; Carlo Dionisi-Vici; Filippo Maria Santorelli; Enrico Bertini; Rosalba Carrozzo
Journal:  Neurogenetics       Date:  2012-09-18       Impact factor: 2.660

9.  PRICKLE3 linked to ATPase biogenesis manifested Leber's hereditary optic neuropathy.

Authors:  Jialing Yu; Xiaoyang Liang; Yanchun Ji; Cheng Ai; Junxia Liu; Ling Zhu; Zhipeng Nie; Xiaofen Jin; Chenghui Wang; Juanjuan Zhang; Fuxin Zhao; Shuang Mei; Xiaoxu Zhao; Xiangtian Zhou; Minglian Zhang; Meng Wang; Taosheng Huang; Pingping Jiang; Min-Xin Guan
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

10.  Optic atrophy-associated TMEM126A is an assembly factor for the ND4-module of mitochondrial complex I.

Authors:  Luke E Formosa; Boris Reljic; Alice J Sharpe; Daniella H Hock; Linden Muellner-Wong; David A Stroud; Michael T Ryan
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.